RIV-BIMb-5d
General
Type : Derivative of Rivastigmine,Carbamate,Benzimidazole
Chemical_Nomenclature : 4-(3-(2-(2-Hydroxyphenyl)-1H-benzo[d]imidazole-4-carboxamido) Propyl) Phenyl Ethyl(methyl)carbamate
Canonical SMILES : CCN(C(OC1=CC=C(C=C1)CCCNC(=O)C2=C3C(=CC=C2)[N]C(=N3)C4=CC=CC=C4O)=O)C
InChI : InChI=1S\/C27H28N4O4\/c1-3-31(2)27(34)35-19-15-13-18(14-16-19)8-7-17-28-26(33)21-10-6-11-22-24(21)30-25(29-22)20-9-4-5-12-23(20)32\/h4-6,9-16,32H,3,7-8,17H2,1-2H3,(H,28,33)(H,29,30)
InChIKey : CTXUEVCDCUDZHB-UHFFFAOYSA-N
Other name(s) : RIVBIMb,5d
MW : 472.54
Formula : C27H28N4O4
CAS_number :
PubChem :
UniChem : CTXUEVCDCUDZHB-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
Families :
Stucture :
Protein :
References (1)
| Title : Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease - Vicente-Zurdo_2022_Biomedicines_10_1510 |
| Author(s) : Vicente-Zurdo D , Rosales-Conrado N , Leon-Gonzalez ME , Brunetti L , Piemontese L , Pereira-Santos AR , Cardoso SM , Madrid Y , Chaves S , Santos MA |
| Ref : Biomedicines , 10 :1510 , 2022 |
| Abstract : Vicente-Zurdo_2022_Biomedicines_10_1510 |
| ESTHER : Vicente-Zurdo_2022_Biomedicines_10_1510 |
| PubMedSearch : Vicente-Zurdo_2022_Biomedicines_10_1510 |
| PubMedID: 35884815 |